With 2,483 new coronavirus infections reported in one day, India’s total COVID-19 cases rose to 4, 30, 62,569, while active cases dropped to 15,636, according to data from the Ministry of Health. Union Health updates Tuesday. The death toll jumped to 5 23,622 with 1,399 new fatalities as Assam reconciled 1,347 deaths and Kerala 47 due to the infection, according to data updated as of 8am. “The total number of cases, discharges and deaths provided by Assam in its media bulletin has been considered along with the number of Covid-positive patients who died for other reasons to reflect the current figures. The State has not reported any deaths in the past 24 hours,” the Union Health Ministry said. Kerala has also reported no deaths in the past 24 hours and 47 deaths have been reported as per the appeal. Active cases account for 0.04 percent of total infections, while the national COVID-19 cure rate has been recorded at 98.75 percent, the ministry said.
Here are the latest updates from the coronavirus pandemic:
# Administration expands availability of COVID antiviral pill
President Joe Biden’s administration is taking steps to expand the availability of the life-saving COVID-19 antiviral treatment Paxlovid as it seeks to reassure doctors that there is an adequate supply for those at high risk of serious illness or death from the virus. Paxlovid, produced by Pfizer, was first approved in December. The diet’s supply was initially very limited, but as COVID-19 cases across the country have declined and manufacturing has increased, it is now much more plentiful. The White House is now working to raise awareness of the pill and take steps to make it easier to access.
# Yogi Adityanath insists on carrying out more tests to stop the spread of COVID-19
As COVID-19 cases spike in the NCR, Uttar Pradesh Chief Minister Yogi Adityanath on Tuesday highlighted taking preventive measures and significantly increasing testing to tackle the threat in the NCR. ‘State. Tests of at least 1.5 lakh should be carried out every day and all necessary arrangements should be made for the treatment of those infected, he said. He said infected people who are in isolation at home should be given full information on the Covid protocol they should follow, an official spokesperson said. The chief minister gave the instructions while chairing a meeting with senior officials, he said.
The Drugs Controller General of India (DCGI) has recommended an Emergency Use Authorization (EUA) for Bharat Biotech’s Covaxin for children between 6 and 12 years old. The DCGI also recommended EUA for Biological E’s Corbevax for children 5 to 12 years old and Zydus Cadila’s ZyCoV-D for those over 12 years old.
# Relief, renewal as Singapore drops COVID restrictions
Office workers lined up for trains, restaurants and elevators and delivery people ran from building to building as the buzz returned to Singapore’s business district on Tuesday, its first day without COVID curbs . The city-state’s high-rise commercial heart of banks, malls and global tech companies was once again in full swing, with swarms of people commuting to work and queuing outside restaurants and shops. crowded cafes after authorities lowered the pandemic alert level for the first time. Strict limits on workplaces and gatherings were no more on Tuesday, with employees lingering outside workplaces and public transport teeming with commuters eager for normalcy after two years of lockdown.
# Beijing to test 20 million people for COVID as lockdown jitters rise
Beijing residents joined growing lines of people waiting to be tested for COVID-19 on Tuesday after the Chinese capital stepped up plans for mass testing to 20 million people overnight and stoked concerns about a impending lockdown. Amid comparisons with Shanghai, where more than 1,000 cases were reported in March before widespread restrictions were finally imposed on 26 million people, many Beijing residents flocked to supermarkets to stock up on food and in supplies, fearing sudden local blockages.
First post: STI